IDAI Issues 10 Recommendations on Covid-19 Vaccination for Children

Translator:

Editor:

Petir Garda Bhwana

  • Font:
  • Ukuran Font: - +
  • Medical officers prepare the Sinovac COVID-19 vaccine during the free mass vaccination at the Bali Nusa Dua Convention Center (BNDCC) in Nusa Dua, Bali, Saturday, February 27, 2021. The vaccination which is held for five days for tourism actors and transportation workers is an effort to prepare for the opening foreign tourism with the concept of

    Medical officers prepare the Sinovac COVID-19 vaccine during the free mass vaccination at the Bali Nusa Dua Convention Center (BNDCC) in Nusa Dua, Bali, Saturday, February 27, 2021. The vaccination which is held for five days for tourism actors and transportation workers is an effort to prepare for the opening foreign tourism with the concept of "free covid corridor" in Bali. TEMPO / Johannes P. Christo

    TEMPO.CO, JakartaThe Indonesian Pediatrician Association (IDAI) released 10 recommendations regarding the Covid-19 vaccination for children and adolescents, including contraindications to Covid-19 vaccines. The government reportedly planned to kick off immunization for children aged 12-17 with the Sinovac vaccine.

    The written recommendation dated June 28, 2021, is subject to change at any time according to the latest developments in scientific evidence. The recommendation is issued under consideration that children can be infected and transmit the coronavirus and to break the virus transmission. 

    Based on the government data on covid19.go.id, 12.6 percent of the total Covid-19 cases in Indonesia were children aged 0-18, meaning that 1 in 8 children infected with the virus.

    The ten recommendations are as follow:

    1. The acceleration of Covid-19 vaccination for children using the inactivated vaccine made by Sinovac. The reasons are that the vaccine brand is already available in Indonesia, the phase 1 and phase 2 clinical trials yield good results, and induces high antibodies.

    2. The immunization must be based on the precautionary principle. It should be started for children aged 12-17.

    3. The vaccine dose of 3 ug (0.5 ml) is given by intramuscular injection in the deltoid muscle of the upper arm twice with an interval of one month.

    4. The inoculation for children aged 3-11 must wait for the results of the study to assess safety and dosage with an adequate number of subjects.

    5. Contraindications to the vaccine or children who are not allowed to be inoculated are children with primary immune deficiency, uncontrolled autoimmune disease, having Guillain Barre syndrome, transverse myelitis, acute demyelinating encephalomyelitis, undergoing chemotherapy or radiotherapy due to cancer, receiving severe immunosuppressant or cytostatic treatment, having a fever of 37.5 degrees Celsius or more, recovering from Covid-19 in less than 3 months, other post-immunization events in less than 1 month, being pregnant, having hypertension, diabetes mellitus, and chronic diseases or congenital abnormalities that are not controlled.

    The Covid-19 vaccination for children with cancer in the maintenance phase, chronic disease, or controlled autoimmune disease can follow the general immunization guidelines by first consulting with the doctor in charge.

    6. Inoculation is carried out by health workers under guidelines.

    7. Immunization can be started after considering the readiness of health workers, facilities, infrastructure, and the community.

    8. Simultaneous immunization for all members of a family will be better.

    9. The electronic vaccination records are integrated with parental vaccination records.

    10. The monitoring of possible adverse events after the Covid-19 vaccination or AEFI.

    Read: COVID-19 Vaccinations to Begin Soon for Children Aged 12-17, Says Jokowi

    ANWAR SISWADI (CONTRIBUTOR)